AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3884627
Drug: Glucose plus
RxNorm normalized name: DUO-CARE Glucose Plus Blood Pressure Monitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glucose plus insulin (1 g + 1.5 U/kg bw X h) before and after ischaemic heart arrest
Trial: 3884627
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group received glucose without insulin
Trial: 30285187
Drug: Basal diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal diet supplemented with 5 × 104 cfu/g C. butyricum (CB2)
Trial: 30285187
Drug: Basal diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal diet supplemented with 5 × 104 cfu/g C. butyricum (CB2) or 1 × 105 cfu/g (CB3)
Trial: 29492637
Drug: Fibre supplement
RxNorm normalized name: Fiore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibre supplement (7.5 g of insoluble fibre per serving, twice daily for 2 years)
Trial: 29492637
Drug: Placebo (0.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.8 g of insoluble fibre per serving, twice daily for 2 years)
Trial: 2820202
Drug: Fibre supplement
RxNorm normalized name: Fiore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibre supplement
Trial: 27585414
Drug: Propofol/remifentanil 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol/remifentanil 0.25 μg/kg/min (PRe‐0.25)
Trial: 27585414
Drug: Propofol/remifentanil 0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol/remifentanil 0.125 μg/kg/min (PRe‐0.125)
Trial: 27585414
Drug: Propofol/saline solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol/saline solution (PS)
Trial: 11399215
Drug: Group cognitive-behavioral
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group cognitive-behavioral therapy
Trial: 1975277
Drug: Famotidine 40
RxNorm normalized name: famotidine 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famotidine 40 mg qhs
Trial: 1975277
Drug: Cimetidine 800
RxNorm normalized name: cimetidine 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 800 mg qhs
Trial: 1975277
Drug: Ranitidine 300
RxNorm normalized name: ranitidine 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine 300 mg qhs
Trial: 375376
Drug: 15(R)15 methyl
RxNorm normalized name: METHYLAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15(R)15 methyl prostaglandin E2 (free acid) at doses of 80, 140, 200, and 400 micrograms
Trial: 375376
Drug: 15(R)15 methyl
RxNorm normalized name: METHYLAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15(R)15 methyl prostaglandin E2 (methylester) at doses of 80, 140, and 200 micrograms
Trial: 375376
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 80 micrograms methyl ester and 1.5 mg atropine sulphate
Trial: 25975643
Drug: Multidisciplinary QOL-directed
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multidisciplinary QOL-directed intervention (for those undergoing neoadjuvant therapy)
Trial: 25975643
Drug: Usual medical
RxNorm normalized name: HYDROGEN PEROXIDE 5 mg in 100 mL TOPICAL LIQUID [USUALKLENZ DISINFECTANTSPRAY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual medical care (control group, for those undergoing neoadjuvant therapy)
Trial: 19545384
Drug: Patient Perception
RxNorm normalized name: Herceptin
DrugBank: Trastuzumab (DB00072)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Patient Perception of Study Medication (PPSM) questionnaire
Trial: 15100619
Drug: Moderate alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moderate alcohol consumption (24 g/day of white wine)
Trial: 11778969
Drug: Sequential therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential therapy (ST) with infusional chemotherapy (IC) using VAMP/C-VAMP followed by autologous transplantation and interferon maintenance
Trial: 11778969
Drug: High-dose therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose therapy consolidation
Trial: 8419199
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC) 50 mg on days 2 to 6 of the menstrual cycle
Trial: 8419199
Drug: Cyclofenil 400
RxNorm normalized name: cyclofenil
DrugBank: Cyclofenil (DB13472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclofenil 400 mg on days 3 to 12 of the menstrual cycle
Trial: 30500336
Drug: Self-administered lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered lidocaine gel 2% 20mL intravaginally 15-30min before procedure initiation
Trial: 30500336
Drug: Self-administered lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered lidocaine gel
Trial: 27465818
Drug: Tong Luo
RxNorm normalized name: CAMPHOR (NATURAL) 5 g / MENTHOL 3.4 g TRANSDERMAL POULTICE [TONG LUO QU TONG GAO]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tong Luo Hua Shi (TLHS) 4.8 g/day
Trial: 27465818
Drug: Tong Luo
RxNorm normalized name: CAMPHOR (NATURAL) 5 g / MENTHOL 3.4 g TRANSDERMAL POULTICE [TONG LUO QU TONG GAO]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tong Luo Hua Shi (TLHS) 3.6 g/day
Trial: 17629158
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg of cefaclor twice daily for five to seven days
Trial: 17629158
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg of cefaclor three times daily for five to seven days
Trial: 16209246
Drug: IL-1ra urinary
RxNorm normalized name: IL-1RA
DrugBank: Anakinra (DB00026)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: IL-1ra urinary excretion
Trial: 16209246
Drug: sTNFR I
RxNorm normalized name: IOBENGUANE I 123
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sTNFR I urinary excretion
Trial: 16209246
Drug: sTNFR II
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sTNFR II urinary excretion
Trial: 16209246
Drug: uIL-1ra urinary
RxNorm normalized name: Urinary hCG
DrugBank: Chorionic Gonadotropin (Human) (DB09126)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: uIL-1ra urinary excretion
Trial: 11931374
Drug: Fibrinogen adsorption
RxNorm normalized name: fibrinogen
DrugBank: Fibrinogen human (DB09222)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinogen adsorption treatment (4 treatments for healthy subjects, 144 treatments for patients)
Trial: 11931374
Drug: Fibrinogen adsorption
RxNorm normalized name: fibrinogen
DrugBank: Fibrinogen human (DB09222)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrinogen adsorption treatment
Trial: 8749600
Drug: Progestogen-only pill
RxNorm normalized name: vaginal ring with progestogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Progestogen-only pill (POP)
Trial: 2390880
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg daily
Trial: 2390880
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg daily
Trial: 350232
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg daily
Trial: 2390880
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg daily
Trial: 2390880
Drug: 0 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0 mg (control)
Trial: 6117302
Drug: Intravenous rimiterol
RxNorm normalized name: rimiterol
DrugBank: Rimiterol (DB13559)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous rimiterol (1050 microgram cumulative dose over 90 min)
Trial: 6117302
Drug: Intravenous rimiterol
RxNorm normalized name: rimiterol
DrugBank: Rimiterol (DB13559)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous rimiterol
Trial: 31557763
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus ticagrelor for 1 month followed by 23-month ticagrelor monotherapy
Trial: 31557763
Drug: Aspirin plus
RxNorm normalized name: Aspirin Plus Antacid Extra Strength
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin plus either clopidogrel or ticagrelor for 12 months followed by 12-month aspirin monotherapy
Trial: 28139362
Drug: Completion axillary
RxNorm normalized name: Iva axillaris pollen
DrugBank: Iva axillaris pollen (DB10764)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Completion axillary lymph node dissection (cALND) - standard treatment
Trial: 19953915
Drug: Dexamethasone, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone, 10 mg IV (Group D)
Trial: 19953915
Drug: Methylprednisolone, 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone, 120 mg IV (Group M)
Trial: 19953915
Drug: Normal saline,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline, 10 ml IV (Group S)
Trial: 17329696
Drug: rHEV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rHEV vaccine
Trial: 16272454
Drug: Adjuvant hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjuvant hormonal therapy and adjuvant chemotherapy
Trial: 16272454
Drug: Novel molecular
RxNorm normalized name: Molecular AF
DrugBank: Tolnaftate (DB00525)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Novel molecular targeted therapies (trastuzumab)
Trial: 11835924
Drug: Ibuprofen 800
RxNorm normalized name: ibuprofen 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen 800 mg 3 times daily or diclofenac 75 mg twice daily
Trial: 10800498
Drug: Cytokine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokine therapy (interferon-alpha)
Trial: 10800498
Drug: Cytokine therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokine therapy (interleukin-2)
Trial: 10800498
Drug: Conventional therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapies (cytotoxic chemotherapies)
Trial: 10800498
Drug: Immunotherapy approaches
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy approaches
Trial: 1688980
Drug: Nifedipine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (0.3 micrograms/kg/min infusion)
Trial: 1688980
Drug: Enoximone (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoximone (0.5 mg/kg bolus)
Trial: 6784924
Drug: Mannitol (37.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mannitol (37.5 g by 6-hour infusion)
Trial: 6784924
Drug: Cisplatin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin (100 mg/m2 every 21-28 days)
Trial: 26547100
Drug: REG1 (pegnivacogin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: REG1 (pegnivacogin 1 mg/kg bolus followed by 80% reversal with anivamersen)
Trial: 22133650
Drug: Verapamil-sustained-release-led (Ve-led)
RxNorm normalized name: verapamil Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil-sustained-release-led (Ve-led) treatment strategy
Trial: 22133650
Drug: Atenolol-led (At-led)
RxNorm normalized name: Atenolol
DrugBank: Atenolol (DB00335)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atenolol-led (At-led) treatment strategy
Trial: 18337008
Drug: AMG 517
RxNorm normalized name: AMG 108
DrugBank: AMG 108 (DB05545)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AMG 517 (TRPV1 antagonist)
Trial: 16508298
Drug: Donepezil (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil (5 mg/day for 4 weeks, 10 mg/day thereafter)
Trial: 14624937
Drug: 2.0 g/kg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g/kg/d protein feeding regime
Trial: 14624937
Drug: Escalating isocaloric
RxNorm normalized name: peanut allergenic extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escalating isocaloric protein feeding regime (1.5, 2.0, and 2.5 g/kg/d)
Trial: 14624937
Drug: 2.5 g/kg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 g/kg/d protein intake
Trial: 14624937
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (if enteral feeding not tolerated)
Trial: 11965831
Drug: Cholesterol lowering
RxNorm normalized name: Cholesterol
DrugBank: Cholesterol (DB04540)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholesterol lowering therapy
Trial: 11965831
Drug: Antiplatelet therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antiplatelet therapy with aspirin
Trial: 11965831
Drug: Multifactorial approach
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multifactorial approach (including improved glycaemic control, aggressive management of dyslipidaemia and hypertension, anti-platelet therapy, reduction of insulin resistance)
Trial: 1922250
Drug: Calcium supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplementation (2 g per day of elemental calcium in the form of calcium carbonate)
Trial: 28327089
Drug: De-escalation of
RxNorm normalized name: sangre de grado
FDA approved: no
EMA approved: no
PMDA approved: no
Description: De-escalation of elective radiation dose with introduction of an intermediate dose-level for selected lymph nodes.
Trial: 28327089
Drug: Standard elective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard elective radiation dose without de-escalation.
Trial: 26489756
Drug: Guided self-help
RxNorm normalized name: loratadine
DrugBank: Loratadine (DB00455)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Guided self-help (GSH) based on cognitive behaviour therapy (CBT)
Trial: 21234579
Drug: Choline citrate
RxNorm normalized name: Choline citrate
DrugBank: Choline (DB00122)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Choline citrate (300.2 mg intravenously every 12 hours until defecation)
Trial: 17306222
Drug: Internet administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Internet administration of the Obsessive Compulsive Inventory and the Obsessive Beliefs Questionnaire-44
Trial: 15469788
Drug: Pravastatin 40
RxNorm normalized name: pravastatin 40 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 40 mg once a day
Trial: 9586915
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and radiation therapy with warfarin (regimen I)
Trial: 9586915
Drug: Chemotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy and radiation therapy without warfarin (regimen II)
Trial: 9586915
Drug: ACE chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE chemotherapy
Trial: 9586915
Drug: PCE chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCE chemotherapy and RT
Trial: 31420057
Drug: Oral Nigella
RxNorm normalized name: Nigella sativa seed oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Nigella sativa oil (1000 mg per capsule, 2 capsules per day for 8 weeks)
Trial: 28509813
Drug: Placebo (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (2 capsules per day for 8 weeks)
Trial: 27347857
Drug: Extracorporeal shockwave
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal shockwave therapy (ESWT) combined with eccentric training
Trial: 22026565
Drug: Speech and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Speech and language therapy (average 6 hours over 6 months)
Trial: 11903702
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy assessment and appropriate treatments/equipment before release
Trial: 9346275
Drug: 100 microg
RxNorm normalized name: Digoxin 100 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 microg vaccine
Trial: 9346275
Drug: 500 microg
RxNorm normalized name: Etizolam 500 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 microg vaccine
Trial: 7946857
Drug: Fentanyl 2-ng
RxNorm normalized name: fentanyl 1.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 2-ng ml-1
Trial: 7946857
Drug: Fentanyl 1-ng
RxNorm normalized name: fentanyl 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 1-ng ml-1
Trial: 27547135
Drug: Bone marrow
RxNorm normalized name: bone marrow
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bone marrow mononuclear cell (BMC) injections
Trial: 27547135
Drug: Cell‐free injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cell‐free injections of a placebo
Trial: 31806930
Drug: Ranibizumab injections
RxNorm normalized name: Ranibizumab
DrugBank: Ranibizumab (DB01270)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ranibizumab injections
Trial: 24053892
Drug: Ranibizumab injections
RxNorm normalized name: Ranibizumab
DrugBank: Ranibizumab (DB01270)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ranibizumab injections + laser photocoagulation
Trial: 21126238
Drug: Inhalation induction
RxNorm normalized name: human sputum, Bordetella pertussis infected
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation induction with sevoflurane (S 1.5, 2.0, 2.5, 3.0)
Trial: 21126238
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (C) with 2.5% thiopental 5 mg/kg
Trial: 8060544
Drug: Oral acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acyclovir (800 mg, four times daily)
Trial: 3051873
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml 1% mepivacaine with epinephrine
Trial: 3051873
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml 1% mepivacaine without epinephrine
Trial: 3051873
Drug: 20 ml
RxNorm normalized name: Exact-Med, 20 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 ml 1% mepivacaine with and without epinephrine
Trial: 30156130
Drug: Herbal compress
RxNorm normalized name: Ulva compressa extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herbal compress treatment
Trial: 12870566
Drug: Reboxetine (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reboxetine (4 mg b.d.)
Trial: 16204325
Drug: Paroxetine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (20 mg mane)
Trial: 11112113
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 250 microg twice daily, FP 500 microg twice daily, FP 1,000 microg twice daily
Trial: 11112113
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) 400 microg twice daily, BUD 800 microg twice daily, BUD 1,600 microg twice daily
Trial: 26108524
Drug: Vitamins C
RxNorm normalized name: MULTIVITAMINS CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamins C and E with 0.025% tretinoin cream
Trial: 26108524
Drug: Urea-cream (placebo)
RxNorm normalized name: urea Topical Cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urea-cream (placebo)
Trial: 25014687
Drug: Lanreotide (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanreotide (120 mg, once every 28 days for 96 weeks)
Trial: 23060037
Drug: Selenium (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium (200 μg daily as selenized yeast)
Trial: 18040528
Drug: 30 ml
RxNorm normalized name: Vial M/T 30 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 ml elderberry extract (278 mg total anthocyanins)
Trial: 18040528
Drug: 200 ml
RxNorm normalized name: Bag Top-Fill, 1200 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 ml elderberry extract (1852 mg total anthocyanins)
Trial: 12380791
Drug: Fleroxacin 400
RxNorm normalized name: fleroxacin 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fleroxacin 400 mg orally once daily for 3 weeks
Trial: 12380791
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (cefazolin plus gentamicin/cephalexin) for 3 to 4 weeks
Trial: 2290723
Drug: TAC (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TAC (all formulations)
Trial: 29752179
Drug: Lovaza (1.86
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovaza (1.86 g of EPA and 1.5 g of DHA daily)
Trial: 15475488
Drug: Sildenafil, 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil, 50 mg
Trial: 9389781
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g (1 mg oestradiol) transdermal oestradiol gel continuously combined with 10 mg medroxyprogesterone acetate orally 12 days either monthly or every third month
Trial: 2437753
Drug: Atracurium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium infusion (0.5 mg X kg‐1 bolus followed by 0.29‐0.44 mg X kg‐1 X h‐1 maintenance infusion)
Trial: 2437753
Drug: Atracurium infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atracurium infusion